Work

Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer

Year: 2017

Type: article

Study design: Observational Study

Source: Pancreas

DOI: 10.1097/mpa.0000000000000760

Authors: Hideyuki Hayashi, Takashi Kohno, Hideki Ueno, Nobuyoshi Hiraoka, Shunsuke Kondo, Motonobu Saito, Yoko Shimada, Hitoshi Ichikawa, Mamoru Kato, Tatsuhiro Shibata, Chigusa Morizane, Yasunari Sakamoto, Kazuaki Shimada, Yoshito Komatsu, Naoya Sakamoto, Takuji Okusaka

Institutions: Hokkaido University, National Cancer Centre Japan, Hokkaido University Hospital, National Cancer Center Hospital, National Cancer Center Research Institute

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Award: Driver and druggable oncogene aberrations in KRAS mutation-negative pancreatic ductal adenocarcinoma

OpenAlex ID: W2573972894

FWCI: 5.302

Cites: 29

Cited by: 87

Related to: 10